When seniors with cancer are being treated with combination therapies, providers need to keep in mind more than just the complex regimens they’re administering, said Ginah Nightingale, PharmD, associate professor of pharmacy practice at Jefferson College of Pharmacy.
When seniors with cancer are being treated with combination therapies, providers need to keep in mind more than just the complex regimens they’re administering, said Ginah Nightingale, PharmD, associate professor of pharmacy practice at Jefferson College of Pharmacy.
Transcript
What are the special challenges for seniors with cancer being treated with combination therapies?
Well, I think some of the challenges are to be able to understand these complex regimens, because I think sometimes when we think of cancer therapies, we think of just the cancer therapies. It’s not really just the cancer therapies, it’s also the supportive care therapies that are added to these combination therapies, taking into account antiemetics, taking into account pain medication, taking into account antibiotics that could be used to prevent infections.
So, it can actually be quite a number of volume of medications that can be added to their existing number of medications depending on if they have diabetes, hypertension, dyslipidemia. It’s very important to make sure that the patient is actually able to manage other medications at baseline before we add combination chemo therapy and then all of the supportive care therapies that get added to that mix.
What steps do you take to coordinate care between the oncologist and the primary care physician?
So, I think that’s an excellent question. I think that that is an area where there is sparse literature in terms of improving fragmented coordination of care. I think that’s an area that actually requires a bit of attention, because there really is not a gold standard in terms of how to have shared decision making between the oncologist, the primary care physician and then the allied health professionals.
So, I think that is an area that does require a bit of research to determine not only communication, but to be able to determine how we can have shared ownership in terms of managing the patient. I think there is a growing need for research in that area.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More